Nutrient Deficiency Panel for ACE Inhibitor Patients
- $147.23
- $59.90
- Save: 59.32%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: K
Potassium
Also known as: ZN, Plasma
Zinc
The Nutrient Deficiency Panel for ACE Inhibitor Patients panel contains 2 tests with 2 biomarkers .
The Nutrient Deficiency Panel for ACE Inhibitor Patients is a targeted diagnostic tool designed to monitor the levels of specific nutrients that may be affected by the use of ACE inhibitors. ACE inhibitors (Angiotensin-Converting Enzyme inhibitors) are commonly prescribed medications for managing conditions such as hypertension, heart failure, and chronic kidney disease. These medications can impact the balance of certain electrolytes and trace minerals in the body, making it essential to monitor and address potential deficiencies to prevent adverse health effects.
When and Why the Nutrient Deficiency Panel for ACE Inhibitor Patients May Be Ordered
This panel may be ordered for patients who are on long-term ACE inhibitor therapy, especially if they present symptoms indicative of electrolyte imbalance or trace mineral deficiencies. Common symptoms may include muscle weakness, fatigue, palpitations, and immune system dysfunction. It is also ordered as a part of routine monitoring in patients with cardiovascular or kidney conditions to ensure optimal management of their therapy and overall health.
What the Nutrient Deficiency Panel for ACE Inhibitor Patients Checks For
The Nutrient Deficiency Panel for ACE Inhibitor Patients includes tests to measure the levels of essential nutrients impacted by ACE inhibitors:
- Potassium: Potassium is a critical electrolyte involved in maintaining proper muscle function, nerve signaling, and fluid balance. ACE inhibitors can increase potassium levels in the blood, leading to hyperkalemia. Monitoring potassium levels helps manage this risk and adjust treatment as necessary.
- Zinc: Zinc is an essential trace mineral important for immune function, wound healing, DNA synthesis, and cell division. Long-term use of ACE inhibitors can sometimes lead to zinc deficiency, affecting immune response and overall health. Measuring zinc levels ensures that any deficiency can be promptly addressed.
Conditions or Diseases the Nutrient Deficiency Panel for ACE Inhibitor Patients Can Detect
The Nutrient Deficiency Panel for ACE Inhibitor Patients helps detect conditions associated with nutrient imbalances caused by ACE inhibitor therapy:
- Hyperkalemia: Elevated potassium levels in the blood can lead to serious cardiac issues, including arrhythmias, muscle weakness, and fatigue. The test measures potassium levels to detect hyperkalemia early, allowing for timely interventions such as dietary modifications or adjustments in medication.
- Zinc Deficiency: Low levels of zinc can impair immune function, slow wound healing, and affect taste and smell. The test measures zinc levels to diagnose deficiency and guide appropriate supplementation or dietary changes.
How a Healthcare Professional Would Use the Results of the Nutrient Deficiency Panel for ACE Inhibitor Patients
Healthcare professionals use the results of the Nutrient Deficiency Panel for ACE Inhibitor Patients to:
- Manage Hyperkalemia: If high potassium levels are detected, the healthcare provider can recommend dietary changes to reduce potassium intake, adjust the dosage of ACE inhibitors, or prescribe medications that help lower potassium levels. Regular monitoring ensures that potassium levels remain within a safe range.
- Address Zinc Deficiency: Upon identifying a zinc deficiency, the healthcare provider may suggest zinc supplements and advise increasing the intake of zinc-rich foods such as meat, shellfish, legumes, and seeds. Monitoring zinc levels helps ensure the effectiveness of these interventions and the maintenance of adequate zinc status.
Conclusion
The Nutrient Deficiency Panel for ACE Inhibitor Patients is an essential diagnostic tool for monitoring and managing nutrient levels in individuals undergoing ACE inhibitor therapy. By evaluating potassium and zinc levels, this panel helps healthcare providers detect and address hyperkalemia and zinc deficiency, preventing potential complications and supporting overall health. Regular monitoring and timely interventions based on the test results ensure optimal management of therapy and enhance patient outcomes.